Inimex Pharmaceuticals
About:
Inimex Pharmaceuticals is a clinical-stage company focused on the development and commercialization of innate defense regulators.
Website: http://www.inimexpharma.com
Top Investors: BDC Venture Capital, Morningside Group, Roche Venture Fund, Discovery Capital, MDS Capital
Description:
Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body's innate defenses without causing inflammation.
Total Funding Amount:
$28.1M
Headquarters Location:
Burnaby, British Columbia, Canada
Founded Date:
2001-01-01
Contact Email:
info(AT)inimexpharma.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2008-06-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai